Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
NYSE: BHVN · IEX Real-Time Price · USD
38.72
-0.89 (-2.25%)
Apr 24, 2024, 4:00 PM EDT - Market closed

BHVN Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020
Net Income
-408.17-570.28-213.8-118.67
Depreciation & Amortization
6.911.391.390.07
Share-Based Compensation
28.79193.5665.6429.5
Other Operating Activities
40.7477.650.9213.14
Operating Cash Flow
-331.73-297.69-145.84-75.96
Capital Expenditures
-3.05-6.07-0.94-2.7
Acquisitions
0-391.880
Change in Investments
132.88-259.7200
Investing Cash Flow
129.83-304.790.94-2.7
Share Issuance / Repurchase
247.92284.260.40
Other Financing Activities
-36.01483.34138.05152.24
Financing Cash Flow
211.91767.6138.45152.24
Exchange Rate Effect
-0.50.4300
Net Cash Flow
9.52165.55-6.4573.59
Free Cash Flow
-334.77-303.76-146.78-78.65
Free Cash Flow Per Share
-4.70-6.79-3.73-2.00
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).